Ossentrix is an orthopedic technology company developing antimicrobial surface coatings and advanced lattice implants designed to reduce infection and improve bone healing.
Ossentrix is an advanced manufacturing and medtech company specializing in orthopedic implant technology designed to reduce infection and enhance bone healing. The company has developed a dual-platform implant solution addressing the primary causes of implant failure: early infection and poor biological integration. This innovation combines a non-eluting, contact-active antimicrobial surface coating to inhibit bacterial adhesion with an optimized osseointegrated lattice structure that promotes bone ingrowth and fixation stability. Key products include antimicrobial-coated intramedullary nails and patient-specific segmental defect implants. Ossentrix’s technology targets complex fracture, infection revision, and limb-salvage cases, offering critical solutions that help healthcare providers avoid significant financial losses. The company’s pioneering approach represents a significant advancement in orthopedic implant design, contributing to improved patient outcomes and innovation in medical device manufacturing.
Startupsby Glyph